Overview

Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Primary Objective: To demonstrate whether an early fixed Somatostatin treatment improves the complete recovery rate of early postoperative simple small bowel obstruction (EPSSBO) compared with the common daily practice Notes: 1. complete recovery= toleration of solid food+ flatus+ passage+ recovery of bowel movement. 2. common daily practice includes: - NPO (Nil per mouth), re-dehydration, TPN (Total Parenteral Nutrition) if needed. Check & make sure stability of electrolytes daily. - GI (Gastro-Intestinal) depression via NGT (Naso-Gastric Tube) - Discontinue opiates, instead of NSAIDs. (Non-Steroidal Anti-Inflammatory Drugs) - Pro-dynamic drugs or other drugs which may interfere with GI (Gastro-Intestinal) movement eg. anti-histamines, anti-cholinergic, opiates, anti-depressives are not indicated. Secondary Objectives: To investigate whether an early fixed Somatostatin treatment will bring much benefit to EPSSBO pts compared with the common daily practice,for this purpose,the study will investigate the endpoints below.
Phase:
Phase 4
Details
Lead Sponsor:
Nanjing PLA General Hospital
Treatments:
Somatostatin